维普中文期刊产品整合服务
30篇 您的检索式:作者名="Zoutendijk"
    题名 作者 年代 出处 被引量
1Efficacy and tolerance of a combination of tenofovir disoproxil fumarate plus emtricitabine in patients with chronic hepatitis B: a European multicenter study显示文摘Si-Ahmed SN Pradat P Zoutendijk R 2011Antiviral Res2011,92,1:1
2Simitarfrequencies, phenotype and activation status of intrahepaticNK cells in chronic HBV patients after long - term treatmentwith tenofovir disoproxil fumarate (TDF) 显示文摘TJWA ET ZOUTENDIJK R van OORD GW 2016Antiviral Res2016,132,:1
3Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis显示文摘Zoutendijk R Reijnders JG Zoulim F 2013Gut2013,62,:1
4Entecavir treatment for chronic hepatitis B: adaptation is not needed for the majority of naive patients with a partial virological response显示文摘Zoutendijk R Reijnders JG Brown A 2011Hepatology2011,54,2:1
5Methods of feasible directions显示文摘Zoutendijk G 1960Elsevier Science Amsterdam Netherlands1960,1960,:1
6Pegylated interferon results in higher serological, but not virological, response rates when compared to continuous entecavir显示文摘Sormeveld MJ Zoutendijk R Hansen BE 2012Antivir Ther2012,17,8:1
7Hepatitis B e antigen levels and response to peginterferon: Influence of precore and basal core promoter mutants显示文摘Milan J. Sonneveld Vincent Rijckborst Louwerens Zwang Stefan Zeuzem E. Jenny Heathcote Krzysztof Simon Roeland Zoutendijk Ulus S. Akarca Suzan D. Pas Bettina E. Hansen Harry L.A. Janssen 2013Antiviral Research2013,,:1
8Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis显示文摘Zoutendijk R Reijnders JG Zoulim F 2013Gut2013,62,5:1
9Efficacy and toler-ance of a combination of tenofovir disoproxil fumarate plus emtric-itabine in patients with chronic hepatitis B:a European multicen-ter study显示文摘Si-Ahmed SN Pradat P Zoutendijk R 2011Antiviral Res2011,92,1:1
10Hepatitis B surface antigen monitoring and management of chronic hepatitis B 显示文摘Sonneveld M J Zoutendijk R Janssen HL 2011J Viral Hepat2011,18,7:1
11Intrahepatic natural killer cell activation, but not function, is associated with HB sAg levels in patients with HB eAg‐negative chronic hepatitis B显示文摘Eric T. T. L. Tjwa Roeland Zoutendijk Gertine W. Oord Paula J. Biesta Joanne Verheij Harry L. A. Janssen Andrea M. Woltman Andre Boonstra Liver Int0,,3:1
12Close monitoring of hepatitis B surface antigen levels helps classify flares during peginterferon therapy and predicts treatment response显示文摘Sonneveld MJ Zoutendijk R Flink HJ 2013Clin Infect Dis2013,56,1:1
13Hepatitis B surface antigen monitoring and management of chronic hepatitis B显示文摘Sonneveld MJ Zoutendijk R Janssen HL 2011J Viral Hepat2011,18,7:1
14Hepatitis B surface antigen monitoring and management of chronic hepatitis B显示文摘Sonneveld MJ Zoutendijk R Janssen HL 2011J Viral Heioat2011,18,7:1
15Entecavir treat- ment for chronic hepatitis B:adaptation is not needed for the majority of naYve patients with a partial virological re- sponse 显示文摘Zoutendijk R Reijnders JG Brown A 2011Hepatology2011,52,4:1
16Nonlinear progranming computational methods显示文摘Zoutendijk G 1970Integer and Nonlinear Programming1970,143,1:1
17Close monitoringof hepatitis B surface antigen levels helps classify flares during-peginterferon therapy and predicts treatment response显示文摘Sonneveld MJ Zoutendijk R Flink HJ 2013ClinInfect Dis2013,56,1:1
18Entecavir treatment for chronic hepatitis B:adaptation is not need- ed for the majority of naive patients with a partial viro- logical response显示文摘Zoutendijk R Reijnders JG Brown A et a/ 2011Hepatology2011,54,2:1
19Maximizing a function in a convex region显示文摘Zoutendijk G 1959Journal of the Royal Statistical Society1959,21,:1
20Entecavir treatment for chronic hepatitis B : adaptation is not needed for the majority of naive patients with a partial virological response 显示文摘Zoutendijk R Reijnders JG Brown A 2011Hepatology2011,54,2:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费